LYPD3 Recombinant Antibody
Product Specifications
Background
Predicted to enable laminin binding activity. Predicted to act upstream of or within cell-matrix adhesion. Located in extracellular space. [provided by Alliance of Genome Resources, Nov 2021]
Synonyms
C4.4A; FLJ10525; GPI-anchored metastasis-associated protein C4.4A homolog; GPI-anchored metastasis-associated protein homolog; Ly6/PLAUR domain-containing protein 3; LYPD3_HUMAN; Matrigel-induced gene C4 protein; MIG-C4; SHINC3.
Gene ID
27076
Swiss Prot
O95274
Cellular Locus
Cell membrane
Host
Rabbit
Cross Reactivity
Human
Target
LYPD3
Clonality
Recombinant
Isotype
IgG
Conjugation
Unconjugated
Source
KLH conjugated synthetic peptide derived from human LYPD3
Applications
WB, IHC-P, IHC-F, IF, ICC/IF
Purification
Purified by Protein A.
Concentration
1mg/ml
Dilution
WB (WB=1:500-1000), IHC-P (IHC-P=1:50-100), IHC-F (ICC=1:50), IF (IF=1:50-100), ICC/IF (1:50-100)
Buffer
0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Modification
Unmodified
Storage Conditions
Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Gene ID URL
27076
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
